Search - tctmd.com

Displaying 1 - 20 of 883

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2025

Cardiology’s Evidence Crisis and What We Can Do About It

Presenter: Robert W. Yeh

November 14, 2025

Presentation Cardiovascular Interventions 2025

New Guidelines for IVUS: Finally, the Indication is 1A

Presenter: Evan Shlofmitz

November 12, 2025

Presentation ESC 2025

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Presenter: Robin Hofmann

August 31, 2025

Presentation ESC 2025

Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk

Presenter: Brian Bergmark

August 30, 2025

Presentation TCT India 2025

Management in the ICU BEFORE high-risk PCI and/or shock

Presenter: Vijay Chilakamarri

July 25, 2025

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 29, 2025

Presentation ACC 2025

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Presenter: Keyvan Karkouti

March 29, 2025

Presentation Controversies and Advances 2025

The AI Revolution in Clinical Practice: Present & Future

Presenter: Sumeet S. Chugh

January 30, 2025

Presentation Controversies and Advances 2025

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

Presenter: Richard J. Auchus

January 30, 2025

Presentation Controversies and Advances 2025

Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes!

Presenter: Yufei Chen

January 30, 2025

Presentation Controversies and Advances 2025

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Presenter: Kalyanam Shivkumar

January 30, 2025

Presentation Controversies and Advances 2025

Familial Chylomicronemia Syndrome: Emerging Treatment Technologies

Presenter: Peter P. Toth

January 30, 2025

Presentation Controversies and Advances 2025

Cuffless blood pressure devices: Are they ready for prime time?

Presenter: Jennifer L. Cluett

January 30, 2025

Presentation AHA 2024

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Presenter: Steven E. Nissen

November 18, 2024

Presentation AHA 2024

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

Presenter: Marcely Gimenes Bonatto

November 18, 2024

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation TCT 2024

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

Presenter: Ryo Hikida

October 29, 2024

Presentation TCT 2024

What Happens Next? Beyond Statins for Optimizing LDL-C Management After Coronary and Peripheral Intervention

Presenter: David Kwon

October 29, 2024

Advertisement

Cardiology’s Evidence Crisis and What We Can Do About It

New Guidelines for IVUS: Finally, the Indication is 1A

Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial

Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk

Management in the ICU BEFORE high-risk PCI and/or shock

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

The AI Revolution in Clinical Practice: Present & Future

Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net!

Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes!

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Familial Chylomicronemia Syndrome: Emerging Treatment Technologies

Cuffless blood pressure devices: Are they ready for prime time?

Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

TCT 1021: Remaining Cholesterol Crystals Against Lipid-Lowering Therapy as a Residual Risk

What Happens Next? Beyond Statins for Optimizing LDL-C Management After Coronary and Peripheral Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content